
Senador Laboratories Private Limited
About Senador Laboratories Private Limited
Data last updated:
Senador Laboratories Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 31 March 2023.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U21001TS2023PTC171514.
The company has an authorised share capital of ₹1.2 Cr and a paid-up capital of ₹1 Cr. It is led by directors including Carlos Romero Camacho Silos and Bharat Vasudevan.
Its last annual general meeting (AGM) was held on 10 December 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 2C Biotech Park, Hyderabad, Telangana.
As per the financials filed for FY 2024, the company reported a revenue of ₹29.13 Cr. For the same year it recorded a net loss of ₹109.77 Cr (net margin -376.8%) and EBITDA of ₹3.65 Cr (EBITDA margin 12.5%).
As per MCA filings, the company has open charges of ₹40 Cr on record.
Company details
Contact details
Senador Laboratories Private Limited's registered office is in Hyderabad, Telangana.
- Registered AddressPlot 2B & 2C Biotech Park Phase II, Lalgadi Malakpet Medchal Malkajgiri, Hyderabad, Telangana, India – 500101
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Senador Laboratories is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Senador Laboratories Private Limited, buy the company report.
Financials of Senador Laboratories Private Limited
FY 2025 filings availableSenador Laboratories Private Limited reported revenue of ₹29.13 Cr for FY 2024.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹3.65 Cr | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹109.77 Cr | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 12.5% | |
| Net Profit Margin | -376.8% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Senador Laboratories Private Limited, buy the company report.
Board of directors of Senador Laboratories Private Limited
Senador Laboratories has 4 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rafael De Andrade | Additional Director | 12 Mar 2024 | 2 Years 8 Months | Current |
| Carlos Romero Camacho Silos Also directs: Airpharm India Private Limited | Director | 12 Mar 2024 | 2 Years 8 Months | Current |
| Bharat Vasudevan | Director | 12 Mar 2024 | 2 Years 8 Months | Current |
| Ramachandra Kumar Kurumaddali | Director | 12 Mar 2024 | 2 Years 8 Months | Current |
Peer comparison
Senador Laboratories Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Atomlife Healthcare and Research Private Limited | ₹29.2 Cr (FY 2024) | 46.0% | Thiruvananthapuram, Kerala, India | |||
| Senador Laboratories Private Limitedthis company | ₹29.13 Cr (FY 2024) | -₹109.77 Cr | -376.8% | Hyderabad, Telangana, India | ||
| Prowell Lifesciences Private Limited | ₹28.95 Cr (FY 2025) | 101.0% | Faridabad, Haryana, India | |||
| Perdaman Pharmaceuticals Private Limited | ₹28.76 Cr (FY 2025) | 4.0% | New Delhi, Delhi, India |
To see the full peer comparison of Senador Laboratories Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 04 Apr 2025 | 101093991 | Hdfc Bank Limited | ₹40 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Senador Laboratories Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Senador Laboratories Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 16 overdue payments to 12 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 12)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Rakesh Chemicals (Chhatral) | |||
| Ascot Pharmachem Private Limited | |||
| an individual supplier | |||
| an individual supplier | |||
| Autofits Packaging Private Limited |
To see the full MSME payment records of Senador Laboratories Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
No GST registration is on our record for Senador Laboratories Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Senador Laboratories Private Limited has 15 board changes on record since 2023: 5 appointments and 10 cessations. The latest: Bharat Vasudevan ceased to be Additional Director on 29 Dec 2024.
7 earlier events are in the company report.
Frequently asked questions
Senador Laboratories is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 31 March 2023 (3+ years old) and is registered under CIN U21001TS2023PTC171514.
Senador Laboratories has 4 current directors:
- Rafael De Andrade - Additional Director
- Carlos Romero Camacho Silos - Director
- Bharat Vasudevan - Director
- Ramachandra Kumar Kurumaddali - Director
The latest financial statements of Senador Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 10 December 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Senador Laboratories is U21001TS2023PTC171514. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Senador Laboratories was incorporated on 31 March 2023, making it 3+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Senador Laboratories by revenue are Atomlife Healthcare and Research Private Limited, Prowell Lifesciences Private Limited, Perdaman Pharmaceuticals Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Bharat Vasudevan ceased to be Additional Director on 29 Dec 2024. Carlos Romero Camacho Silos ceased to be Additional Director on 29 Dec 2024. Ramachandra Kumar Kurumaddali ceased to be Additional Director on 29 Dec 2024. Senador Laboratories has 15 board changes on record in total.
Senador Laboratories has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 16 overdue payments to 12 micro and small suppliers. The latest return was filed on 29 Apr 2024.
The registered office of Senador Laboratories is at Plot 2B & 2C Biotech Park Phase II, Lalgadi Malakpet Medchal Malkajgiri, Hyderabad, Telangana, India – 500101.
Senador Laboratories operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Senador Laboratories has open charges of ₹40 Cr and no satisfied charges on record as per latest MCA filings.
Senador Laboratories can be reached at its registered office: Plot 2B & 2C Biotech Park Phase II, Lalgadi Malakpet Medchal Malkajgiri, Hyderabad, Telangana, India – 500101.

